Accuray Incorporated
Accuray Incorporated (ARAY) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ARAY · as of Jun 8, 2026
Key Statistics
Explore Accuray Incorporated Data
aray stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 13 · Buy rate: 61.5%
The ARAY analyst consensus is Buy, based on ratings from 13 Wall Street analysts over the past 3 months. The average 12-month price target is $2.00, representing +492.24% upside from the current price of $0.34.
Competitors & Peers
aray competitorsARAY
ANIK
AVR
LNSR
MIST
MXCTStock Performance
Full HistoryAbout Accuray Incorporated
Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Australia, New Zeala…
what is accuray incorporated · aray stock overview · accuray incorporated company profile · who is accuray incorporated ceo · aray NASDAQ · accuray incorporated headquarters · accuray incorporated business segments
About Stock Overview & Key Data
Accuray Incorporated (ARAY) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Feb 8, 2007. As of the latest trading session, ARAY stock price is $0.34, with a market capitalization of $40.4M. The stock has returned -73.48% over the past 12 months and -58.84% year-to-date.
According to 13 Wall Street analysts, the consensus rating for Accuray Incorporated stock is Buy, with an average 12-month price target of $2.00. In fiscal year 2025, Accuray Incorporated reported revenue of $458.5M and net income of -$1.6M. For detailed data — including Accuray Incorporated revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Accuray Incorporated (ARAY) stock price is $0.34. The stock is traded on NASDAQ under the ticker symbol ARAY. The 52-week range is $0.25 – $2.10.